New drug cocktail shows promise for tough head and neck cancers
NCT ID NCT07618624
First seen Jun 06, 2026 ยท Last updated Jun 06, 2026
Summary
This study tests whether giving a combination of three drugs (finotonlimab, cetuximab, and docetaxel) before surgery can shrink tumors in people whose head and neck cancer has come back after prior immunotherapy and chemotherapy. The trial enrolls 42 adults with a specific type of cancer that can still be surgically removed. The main goal is to see how many patients have a major reduction in cancer cells in the removed tissue.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Cancer Hospital and Institute of Guangzhou Medical University
Guangzhou, Guangdong, China
-
Affiliated Hospital of Guangdong Medical University
Zhanjiang, Guangdong, China
-
Cancer Hospital of Shantou University Medical College
Shantou, Guangdong, China
-
Guangzhou First People's Hospital
Guangzhou, Guangdong, China
-
Shenzhen Second People's Hospital
Shenzhen, Guangdong, China
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China
-
The First People's Hospital of Foshan
Foshan, Guangdong, China
-
The Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
-
Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, China
Conditions
Explore the condition pages connected to this study.